Vote!
Efficacy and safety of recombinant human C1‐inhibitor for the treatment of attacks of hereditary angioedema: European open‐label extension study
Conclusions and clinical relevanceTreatment with rhC1‐INH provides fast‐onset relief for an HAE attack, with a high rate of therapeutic response maintained throughout subsequent attacks.© 2012 Blackwell Publishing Ltd (Source: Clinical and Experimental Allergy)...
Published By: MedWorm - Wednesday, 22 February